ctrl K

AI Score

Unlock

TScan Therapeutics Inc. (TCRX)

AI Score

Unlock

1.27

-0.11 (-7.97%)

At close: Apr 01, 2025, 3:59 PM

1.31

3.16%

After-hours: Apr 01, 2025, 07:59 PM EDT

TScan Therapeutics Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	2.82M	21.05M	13.54M	10.14M	1.08M
Cost of Revenue	n/a	88.15M	5.14M	3.33M	20.58M
Gross Profit	2.82M	-67.1M	8.4M	6.81M	-19.49M
Operating Income	-134.82M	-93.46M	-66.64M	-48.64M	-26.23M
Interest Income	12.06M	8M	1.59M	16K	106K
Pretax Income	-127.5M	-89.22M	-66.22M	-48.63M	-26.13M
Net Income	-127.5M	-89.22M	-65.81M	-48.63M	-26.02M
Selling & General & Admin	30.29M	26.35M	20.35M	13.83M	6.74M
Research & Development	107.35M	88.15M	59.82M	44.95M	20.58M
Other Expenses	n/a	n/a	1.59M	16K	n/a
Operating Expenses	137.64M	114.51M	80.17M	58.78M	27.32M
Interest Expense	3.65M	3.76M	1.18M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	137.64M	114.51M	80.17M	58.78M	27.32M
Income Tax	n/a	n/a	-415K	3.09M	-106K
Shares Outstanding (Basic)	111.99M	65.6M	24.05M	23.91M	24.94M
Shares Outstanding (Diluted)	111.99M	65.6M	24.05M	23.91M	24.94M
EPS (Basic)	-1.14	-1.36	-2.74	-2.03	-1.04
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-119.74M	-80.1M	-59.91M	-45.3M	-25M
Depreciation & Amortization	4.11M	5.36M	5.14M	3.33M	1.23M